ing. E.F.F. (Laura) Zwarts
ing. E.F.F. (Laura) Zwarts
- Clinical Toxicology
Research Programs
Biography
Biography
I have over 10 years experience as a European registered toxicologist, with a focus on research in neurotoxicity and clinical toxicology. What I like most, is working on research projects that have an impact on society.
My research focuses primarily on poisonings with psychoactive substances via observational human studies. In clinical toxicology, such data are often the sole source of information. Also, such data is valuable to protect public health and develop policy strategies.
Specialities: research, clinical toxicology, neurotoxicology, risk assessment, drugs (MDMA, novel psychoactive substances (NPS), nitrous oxide)
Skills: analytical, project coordination, perseverance, well-organized and structured.
Side Activities
2020-current
Committee Member ‘Coordinatiepunt Assessment en Monitoring Nieuwe Drugs’ (CAM)
- Committee risk assessment 3-MMC
- Member of Workgroup update risk assessment by CAM.
Board Member EAPCCT (European Association of Poisons Centres and Clinical Toxicologists)
- Chair of Workgroup contract Publisher Taylor and Francis
- Member of Workgroup website renewal
- Member of Workgroup Research on Covid-19 effect on EU Poisons Centres.
- Abstract reviewer for annual EAPCCT congresses (since 2019)
Scientific and Meetings Committee Member EAPCCT
2019-current Member of the Research Pool UMCU – research policy
2013-current Reviewer for several journals in Toxicology
https://publons.com/researcher/3231681/laura-hondebrink/
Research Output (63)
van Riel Antoinette, Hunault C C, van den Hengel-Koot I S, Nugteren-van Lonkhuyzen Annette, de Lange D W, Hondebrink L Feb 2022, In: The International journal on drug policy. 100
Essink Sharon, Nugteren-van Lonkhuyzen Johanna J, van Riel Antoinette J H P, Dekker Douwe, Hondebrink Laura 31 Dec 2021, In: Drug and Alcohol Dependence. 231 , p. 1-8
Rietjens Saskia J, Sikma Maaike A, Hunault Claudine C, de Lange Dylan W, Hondebrink Laura 8 Oct 2021, In: British Journal of Clinical Pharmacology. 88 , p. 1288-1297 10 p.
Lonati D., Hondebrink L., Faber K., Hogberg L., Hermanns-Clausen M., Zammit M., Thiermann H. Sep 2021, In: Toxicology Letters. 350 , p. S19-S19
de Lange Prof.dr. D.W. (Dylan), Nugteren-van Lonkhuyzen Annette, Franssen Eric , van Riel Antoinette, Hondebrink Laura 4 Jun 2021, In: Pharmaceutisch Weekblad. 156 , p. 18-20
Nugteren-van Lonkhuyzen Johanna J., Rietjens Saskia J., van Riel Antoinette J. H. P., van den Hengel-Koot Irma S., Contrucci Ramon R., de Lange Dylan W., Hondebrink Laura 3 Jun 2021, In: Clinical Toxicology. 59 , p. 555-556
Hondebrink Laura, Faber Katrin, Zammit Mark, Hoegberg Lotte C. G., Lonati Davide 3 Jun 2021, In: Clinical Toxicology. 59 , p. 542-542
Prins Yoram P., Hondebrink Laura, van den Hengel-Koot Irma S., Litsenburg Ronald, Dekker Douwe 3 Jun 2021, In: Clinical Toxicology. 59 , p. 553-554
Vercoulen Eefje, Hondebrink Laura 2 Jan 2021, In: Critical Reviews in Toxicology. 51 , p. 1-14 14 p.
de Korte Tessa, Nacken Peter, Zwartsen Anne, Westerink Remco, Hondebrink Laura Sep 2020, In: JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS. 105 , p. 2-3